149 related articles for article (PubMed ID: 25264118)
1. Coats disease in a patient with Fanconi anemia: a case report.
Martín-Sanz R; Peña D; López-Miguel A; Coco-Martín MB; González-García H; Álvarez-Guisasola FJ; Pastor JC
Eur J Ophthalmol; 2015; 25(2):182-3. PubMed ID: 25264118
[TBL] [Abstract][Full Text] [Related]
2. Successful use of intravitreal bevacizumab and pascal laser photocoagulation in the management of adult Coats' disease.
Raoof N; Quhill F
Middle East Afr J Ophthalmol; 2013; 20(3):256-8. PubMed ID: 24014992
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal Ranibizumab for myopic choroidal neovascularization after pars plana vitrectomy and silicone oil tamponade.
Cascavilla ML; Querques G; Querques L; Codenotti M; Bandello F
Eur J Ophthalmol; 2013; 23(6):913-6. PubMed ID: 23813105
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
Ramasubramanian A; Shields CL
Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
[TBL] [Abstract][Full Text] [Related]
5. The effect of intravitreal bevacizumab in the treatment of Coats disease in children.
Wells JR; Hubbard GB
Retina; 2011 Feb; 31(2):427-8; author reply 428. PubMed ID: 21240039
[No Abstract] [Full Text] [Related]
6. Retinal angiomatous proliferation with chorioretinal anastomosis in childhood Coats disease: a reappraisal of macular fibrosis using multimodal imaging.
Sigler EJ; Calzada JI
Retina; 2015 Mar; 35(3):537-46. PubMed ID: 25170864
[TBL] [Abstract][Full Text] [Related]
7. Management of stage 3B Coats disease: presentation of a combined treatment modality and long-term follow-up.
Liang T; Peng J; Zhang Q; Zhu X; Xu Y; Zhao P
Graefes Arch Clin Exp Ophthalmol; 2020 Sep; 258(9):2031-2038. PubMed ID: 32474693
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors.
Saito W; Kase S; Fujiya A; Dong Z; Noda K; Ishida S
Retina; 2013 Oct; 33(9):1959-67. PubMed ID: 23652580
[TBL] [Abstract][Full Text] [Related]
9. "Mommy... I Can't See With My Eye". Coats disease with foveal exudation (Stage 2b).
Yeung HH
J Pediatr Ophthalmol Strabismus; 2016; 53(2):76-7, 89. PubMed ID: 27018878
[No Abstract] [Full Text] [Related]
10. Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy.
Matos R; Beato J; Silva M; Silva S; Brandão E; Falcão-Reis F; Penas S
Ophthalmic Genet; 2017; 38(5):490-493. PubMed ID: 28121209
[TBL] [Abstract][Full Text] [Related]
11. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center.
Shields CL; Udyaver S; Dalvin LA; Lim LS; Atalay HT; L Khoo CT; Mazloumi M; Shields JA
Indian J Ophthalmol; 2019 Jun; 67(6):772-783. PubMed ID: 31124485
[TBL] [Abstract][Full Text] [Related]
12. Visual outcomes after treatment in pediatric patients with Coats' disease.
Chiu HH; Wan MJ; Kertes PJ; Muni RH; Lam WC
Can J Ophthalmol; 2019 Dec; 54(6):647-652. PubMed ID: 31836093
[TBL] [Abstract][Full Text] [Related]
13. Current management of Coats disease.
Sigler EJ; Randolph JC; Calzada JI; Wilson MW; Haik BG
Surv Ophthalmol; 2014; 59(1):30-46. PubMed ID: 24138893
[TBL] [Abstract][Full Text] [Related]
14. Retinal telangiectasis detected during a vision screening examination in a child with hearing loss led to the diagnosis of facioscapulohumeral muscular dystrophy.
Lee GD; Chen VM; Barnes AC; Goldman DR; Duker JS
J AAPOS; 2014 Jun; 18(3):303-5. PubMed ID: 24924285
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant anti-VEGF therapy in Coats' disease].
Fiorentzis M; Stavridis E; Seitz B; Viestenz A
Ophthalmologe; 2015 May; 112(5):451-4. PubMed ID: 25134462
[TBL] [Abstract][Full Text] [Related]
16. TRANSCLERAL DRAINAGE OF SUBRETINAL FLUID, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR, AND WIDE-FIELD IMAGING-GUIDED LASER IN COATS EXUDATIVE RETINAL DETACHMENT.
Stanga PE; Jaberansari H; Bindra MS; Gil-Martinez M; Biswas S
Retina; 2016 Jan; 36(1):156-62. PubMed ID: 26355946
[TBL] [Abstract][Full Text] [Related]
17. Exudative retinal astrocytic hamartoma diagnosed and treated with pars plana vitrectomy and intravitreal bevacizumab.
Nakayama M; Keino H; Hirakata A; Okada AA; Terado Y
Eye (Lond); 2012 Sep; 26(9):1272-3. PubMed ID: 22722490
[No Abstract] [Full Text] [Related]
18. Treatment of Coats' disease with intravitreal bevacizumab.
Ray R; Barañano DE; Hubbard GB
Br J Ophthalmol; 2013 Mar; 97(3):272-7. PubMed ID: 23269680
[TBL] [Abstract][Full Text] [Related]
19. Management of Coats disease with bevacizumab in 2 patients.
Venkatesh P; Mandal S; Garg S
Can J Ophthalmol; 2008 Apr; 43(2):245-6. PubMed ID: 18347637
[No Abstract] [Full Text] [Related]
20. Effect of Serial Intrasilicone Oil Bevacizumab Injections in Eyes With Recurrent Proliferative Vitreoretinopathy Retinal Detachment.
Hsu J; Khan MA; Shieh WS; Chiang A; Maguire JI; Park CH; Garg SJ; Ho AC; Kaiser RS
Am J Ophthalmol; 2016 Jan; 161():65-70.e1-2. PubMed ID: 26432568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
